CD8A and colorectal carcinoma: In addition, a scoring system called Immunoscore, which summarises the densities of CD3 + and CD8 + T-cell effectors within the tumour and its invasive margins, has been shown to be useful in predicting the clinical outcome of patients with CRC.19,20